Sarepta Therapeutics Statistics
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.50+0.19 (+1.10%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 17.38 -0.69%
Sarepta Therapeutics by the numbers
Sarepta Therapeutics has a market capitalization of $1.85 billion based on 105.63M shares outstanding. With trailing EPS of $-1.57, Sarepta Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.7% below its 50-day average and 8.2% below its 200-day average.
Average daily trading volume is 2.98M shares, or about $52.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SRPT valuation vs. peer median
| Metric | SRPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.85B | $1.85B | +0% |
| Avg. volume | 2.98M | 1.32M | +126% |
Peer median across 8 companies: ZBIO, XERS, ADRX, XNCR, BHVN, TRVI, PVLA, AGIO.
Valuation
- Market cap
- $1.85B
- Forward P/E
- 7.26
- EPS (TTM)
- $-1.57
- Shares outstanding
- 105.63M
Price and trading
- Previous close
- 17.31
- Open
- 17.28
- Day range
- 16.98 – 17.65
- 52-week range
- 14.68 – 24.68
- 52-week change
- -24.31%
- Beta
- —
- Volume
- 2.87M
- Average volume
- 2.98M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 1.85B
- Forward Pe
- 7.26
- Eps
- -1.57
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.68
- Week52 Low
- 14.68
- Avg Volume
- 2.98M
- Shares Outstanding
- 105.63M
- Ma50
- 18.96
- Ma200
- 19.06
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -29.09%
- Pct From52w Low
- 19.21%